FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称TRILACICLIB
异名/同义词2'-((5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-2-YL)AMINO)-7',8'-DIHYDRO-6'H-SPIRO(CYCLOHEXANE-1,9'-PYRAZINO(1',2':1,5)PYRROLO(2,3-D)PYRIMIDIN)-6'-ONE
7',8'-DIHYDRO-2'-((5-(4-METHYL-1-PIPERAZINYL)-2-PYRIDINYL)AMINO)SPIRO(CYCLOHEXANE-1,9'(6'H)-PYRAZINO(1',2':1,5)PYRROLO(2,3-D)PYRIMIDIN)-6'-ONE
G1T28
G-1T28
SPIRO(CYCLOHEXANE-1,9'(6'H)-PYRAZINO(1',2':1,5)PYRROLO(2,3-D)PYRIMIDIN)-6'-ONE, 7',8'-DIHYDRO-2'-((5-(4-METHYL-1-PIPERAZINYL)-2-PYRIDINYL)AMINO)-
TRILACICLIB
TRILACICLIB [INN]
TRILACICLIB [USAN]
TRILACICLIB [WHO-DD]
CAS登记号1374743-00-6
物质唯一标识(Unique Ingredient Identifier)U6072DO9XG
分子式10565
国际化合物标识(International Chemical Identifier,InChI)DE-111
SMILESC24H30N8O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型PDGKHKMBHVFCMG-UHFFFAOYSA-N / O=C1c2n(C3(CN1)CCCCC3)c4c(c2)cnc(n4)Nc5ccc(cn5)N6CCN(CC6)C
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System